Skip to main content

Table 1 The relationship between TMS1 promoter methylation and clinicopathology parameter of cervical cancer

From: CpG island methylation of TMS1/ASC and CASP8 genes in cervical cancer

Characteristic overall present Absent P Value
< 50 44 2(4.5%) 42(95.4%) 0.65
> 50 36 3(8.3%) 33(91.6%)  
Smoker 5 1(20%) 4(80%) 0.28
Nonsmoker 75 4(5.3%) 71(94.6%)  
Histological type SCC 68 4(5.8%) 64(94.1%) 0.56
AC 12 1(8.3%) 11(91.6%)  
Stage     
Ib 46 1(2.2%) 45(97.8%) 0.10
IIa 12 2(16.6%)IIb 10(83.3%)  
IIb 19 2(10.5%) 17(89.4%)  
IIIb 3 - 3(100%)